Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 7/20 | 0.41 |
| ▸ | NFKB2 | Q00653 | 7/20 | 0.41 |
| ▸ | RELA | Q04206 | 7/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 6/20 | 0.40 |
| ▸ | HPGD | P15428 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | GAA | P10253 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | GLA | P06280 | 3/20 | 0.40 |
| ▸ | PKM | P14618 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 8/20 | 0.35 |
| ▸ | NPC1 | O15118 | 7/20 | 0.35 |
| ▸ | STAT1 | P42224 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15431004 | 0.93 | KDM4E (0.44) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL16453012 | 0.91 | KDM4E (0.41) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL29311291 | 0.90 | KDM4E (0.47) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL29311349 | 0.90 | RAB9A (0.42) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL27049592 | 0.88 | KDM4E (0.47) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL16453094 | 0.87 | PTGER4 (0.38) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL15431030 | 0.87 | KDM4E (0.41) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL16453072 | 0.85 | KDM4E (0.38) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL29311347 | 0.85 | RAB9A (0.44) | KDM4ENFKB1NFKB2RELASMN1; SMN2 | |
| SCHEMBL29311290 | 0.85 | KDM4E (0.49) | KDM4ENFKB1NFKB2RELASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | DOOSAN CORPORATION (KR) | 2019-03-19 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | DOOSAN CORPORATION (KR) | 2015-06-18 | — | — | US | disclosed |
| WO-2014010810-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | 주식회사 두산 (KR) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10236451-B2 | Compound and organic electroluminescent device comprising the same | VDAC1, PIEZO1, SLCO4C1 | KDM4E 692/4885NFKB1 3719/4885NFKB2 3346/4885 |
| US-20150171344-A1 | NOVEL COMPOUND AND ELECTROLUMINESCENT DEVICE INCLUDING SAME | VDAC1, ALDH2, VDAC2 | KDM4E 604/4885NFKB1 3965/4885NFKB2 3626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.